Financial incentives to help adolescents manage type 1 diabetes
InvesT1D: Promoting Adolescent Investment in Diabetes Care
This study is testing if giving financial rewards to teenagers with type 1 diabetes can help them manage their condition better compared to regular care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 96 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | Harvard Pilgrim Health Care Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT06384911 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of a financial incentives program called InvesT1D in supporting diabetes management among adolescents with type 1 diabetes. Participants will be randomly assigned to either receive financial incentives for achieving diabetes self-management goals or continue with usual care. The study will assess changes in glucose levels and self-reported outcomes from both adolescents and their caregivers. A total of 96 participants will be involved, with data collected to compare the outcomes between the two groups.
Who should consider this trial
Good fit: Ideal candidates are adolescents aged 12 and older with type 1 diabetes who use a continuous glucose monitor and have low adherence to diabetes management goals.
Not a fit: Patients who already have high adherence to diabetes management or do not use a continuous glucose monitor may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could enhance diabetes management and improve health outcomes for adolescents with type 1 diabetes.
How similar studies have performed: Other studies have shown promise in using financial incentives for health behavior changes, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with type 1 diabetes ≥12 months * Utilize a continuous glucose monitor (CGM) to support diabetes management * Average daily CGM use is less than or equal to 70% of the time and/or their baseline average insulin bolus administration is less than or equal to 3 times a day * Are using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration * Cognitively able to participate in incentive program and complete surveys * Have access to a mobile phone to receive information about goal attainment and incentive updates * Have the ability to upload glucose and insulin administration data remotely per processes used by participant's diabetes care team * Caregivers are willing to participate in study and complete surveys Exclusion Criteria: * At time of screening, average CGM wear is greater than 70% of the time or baseline average insulin bolus administration is greater than 3 times a day * Adolescent is not interested in using diabetes technology that allows for tracking of bolus insulin administration if participant wants to work on improving daily bolus insulin administration * Cognitively or physically unable to participate * Adolescent is a ward of the state * Severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes * Caregivers are not willing to participate in study and complete surveys
Where this trial is running
Seattle, Washington
- Seattle Children's — Seattle, Washington, United States (Recruiting)
Study contacts
- Study coordinator: Catherine Pihoker, MD
- Email: catherine.pihoker@seattlechildrens.org
- Phone: 206-987-2637
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.